MTCYBP6

Across TCGA pan-cancer cohorts, MTCYBP6 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated MTCYBP6 data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher MTCYBP6 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTCYBP6 expression acts as an unfavorable survival marker.

UCEC and OV are the cancer types where MTCYBP6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Tertile	All	0.495	0.876	<.001	108	view →
OV	OS	Tertile	All	0.244	0.690	.006	54	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MTCYBP6–UCEC (OS)

Open the UCEC breakdown →